Arnold Library

Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR.

Oehler, VG and Qin, J and Ramakrishnan, R and Facer, G and Ananthnarayan, S and Cummings, C and Deininger, M and Shah, N and McCormick, F and Willis, S and Daridon, A and Unger, M and Radich, J (2008) Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. ISSN 1476-5551

[img] Text (Complete manuscript)
OehlerManuscript_121108.doc
Restricted to Repository staff only
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (370Kb) | Request a copy
Article URL: http://www.nature.com/leu/journal/vaop/ncurrent/ab...

Abstract

No abstract available

Item Type: Article
Additional Information: This article is available to subscribers only via the Article URL given above.
DOI: 10.1038/leu.2008.183
PubMed ID: 18615105
NIHMSID: NIHMS82770
Grant Numbers: K23 CA106796-04, P01 CA18029-33
Keywords or MeSH Headings: Fusion Proteins, bcr-abl/genetics* Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis* Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics* Microfluidic Analytical Techniques/instrumentation Nanotechnology/instrumentation* Point Mutation* Polymerase Chain Reaction/methods* Polymerase Chain Reaction/standards Sensitivity and Specificity
Subjects: Cellular and Organismal Processes > Genetic processes > Mutation
Diseases > Hematologic and lymphatic diseases > Leukemia
Research Methodologies
Depositing User: Library Staff
Date Deposited: 11 Dec 2008 21:46
Last Modified: 14 Feb 2012 14:42
URI: http://authors.fhcrc.org/id/eprint/197

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy